Genomic Press Jun 10 2025 In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New York University (NYU), reveals how a serendipitous conversation in 2006 launched his journey into investigating psychedelic compounds as potential breakthrough treatments for some of psychiatry's most challenging conditions. Rediscovering a forgotten therapeutic approach "Hidden in plain sight," as Dr. Ross describes it, was an extensive body of